Literature DB >> 21209028

Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas.

Jitske Tiemensma1, Adrian A Kaptein, Alberto M Pereira, Johannes W A Smit, Johannes A Romijn, Nienke R Biermasz.   

Abstract

CONTEXT AND
OBJECTIVE: Coping strategies may affect quality of life, which is decreased in patients after treatment for Cushing's disease, acromegaly, or nonfunctioning pituitary macroadenomas (NFMA). We aimed to explore coping strategies in these patients because this has never been done before.
DESIGN: We conducted a cross-sectional study.
SUBJECTS: We included patients treated for Cushing's disease (n = 42), for acromegaly (n = 80), and for NFMA (n = 61). These patients were compared with three reference populations: an a-select sample from the Dutch population (n = 712), patients with chronic pain (n = 59), and patients receiving primary care psychology services (n = 525). Furthermore, the three patient groups were compared with each other. Coping strategies were assessed by the Utrecht Coping List.
RESULTS: Compared with the a-select sample, patients with pituitary adenomas reported less active coping (P < 0.0001), sought less social support (P < 0.0001), and reported more avoidant coping (P = 0.008). In contrast, patients treated for pituitary adenomas reported somewhat better coping strategies than patients with chronic pain and those with psychological disease. When patients with different pituitary adenomas were compared, patients treated for Cushing's disease sought more social support than patients treated for NFMA (P = 0.035).
CONCLUSIONS: Patients treated for pituitary adenomas display different and less effective coping strategies compared with healthy controls. A targeted intervention might help to stimulate patients to use a more active coping strategy and to seek social support instead of an avoiding coping strategy. This might, in turn, improve their quality of life.

Entities:  

Mesh:

Year:  2011        PMID: 21209028     DOI: 10.1210/jc.2010-2490

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  24 in total

1.  Neuropsychological functioning in acromegaly: towards identification of modifiable factors to improve long-term care after remission.

Authors:  Alberto M Pereira
Journal:  Endocrine       Date:  2015-09-08       Impact factor: 3.633

2.  The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats.

Authors:  Mano Aliczki; Istvan Barna; Ibolya Till; Maria Baranyi; Beata Sperlagh; Steven R Goldberg; Jozsef Haller
Journal:  Psychopharmacology (Berl)       Date:  2016-01-26       Impact factor: 4.530

3.  Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL.

Authors:  Cornelie D Andela; Nicolasine D Niemeijer; Margreet Scharloo; Jitske Tiemensma; Shaaji Kanagasabapathy; Alberto M Pereira; Noëlle G A Kamminga; Ad A Kaptein; Nienke R Biermasz
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

Review 4.  Update on quality of life in patients with acromegaly.

Authors:  Iris Crespo; Elena Valassi; Susan M Webb
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

5.  Perception of health and cognitive dysfunction in acromegaly patients.

Authors:  Iris Crespo; Susan M Webb
Journal:  Endocrine       Date:  2014-03-25       Impact factor: 3.633

6.  Pituitary tumors: coping with ‘cured’ pituitary tumors.

Authors:  Susan M Webb
Journal:  Nat Rev Endocrinol       Date:  2011-05       Impact factor: 43.330

7.  Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study.

Authors:  Chris G Yedinak; Maria Fleseriu
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

8.  Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly.

Authors:  S H P P Roerink; M A E M Wagenmakers; J F Wessels; R B T M Sterenborg; J W Smit; A R M M Hermus; R T Netea-Maier
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

9.  Impact of exercise on quality of life and body-self perception of patients with acromegaly.

Authors:  Esra Hatipoglu; Nuri Topsakal; Oya Erkut Atilgan; Nilufer Alcalar; Asiye Filiz Camliguney; Mutlu Niyazoglu; Hasan Birol Cotuk; Pinar Kadioglu
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

10.  Quality of life in female patients with acromegaly.

Authors:  O Celik; P Kadioglu
Journal:  J Endocrinol Invest       Date:  2012-11-26       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.